Relay Therapeutics, Inc. (NASDAQ:RLAY) Stock Rated “Moderate Buy” by Sell-Side Analysts
Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the fourteen brokerages that are presently covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell rating, one has given a hold rating, ten have issued a buy rating and two have […]
3 Oct 04:58 · The Cerbat Gem